HIGHLIGHTS
- who: Claudia Soledad SepĂșlveda and colleagues from the Laboratory of Virology, Biochemistry Department, School of Sciences, University of Buenos Aires (UBA), Ciudad Universitaria, Buenos Aires, Argentina have published the paper: Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy, in the Journal: Microorganisms 2022, 10, 1631. of 26/07/2022
- what: Two different strategies are usually employed for viral chemotherapy development: the viral target-based approach, aimed at blocking a virus-encoded protein, which gives rise to the design of direct-acting antivirals (DAA), and the host-targeted approach, aimed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.